PHARMACEUTICAL COMPOSITIONS OF A ERB2 (HER2) INHIBITOR

PHARMACEUTICAL COMPOSITIONS OF A ERB2 (HER2) INHIBITOR

A solid dispersion of N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and processes for preparing the solid dispersion are provided herein. Also, a pharmaceutical composition comprising a solid dispersion of N4-(4-([1,2,4]...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: FRY, David Shank, CRAIG, Christopher Donovan, GAUTSCHI, Jeff, PREIGH, Michael, LINDEMANN, Christopher M, BLOOM, Corey Jay, SMITHEY, Dan, DUBOSE, Devon Brevard
Format: Patent
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator FRY, David Shank
CRAIG, Christopher Donovan
GAUTSCHI, Jeff
PREIGH, Michael
LINDEMANN, Christopher M
BLOOM, Corey Jay
SMITHEY, Dan
DUBOSE, Devon Brevard
description A solid dispersion of N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and processes for preparing the solid dispersion are provided herein. Also, a pharmaceutical composition comprising a solid dispersion of N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and uses thereof are provided herein.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ZA201606123B</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ZA201606123B</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ZA201606123B3</originalsourceid><addsrcrecordid>eNrjZDAL8HAM8nV0dg0N8XR29FFw9vcN8A_2DPH09wtW8HdTcFRwDXIyUtDwcA0y0lTw9PPwdPIM8Q_iYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxUY5GBoZmBmaGRsZOxsSoAQDoSidy</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PHARMACEUTICAL COMPOSITIONS OF A ERB2 (HER2) INHIBITOR</title><source>esp@cenet</source><creator>FRY, David Shank ; CRAIG, Christopher Donovan ; GAUTSCHI, Jeff ; PREIGH, Michael ; LINDEMANN, Christopher M ; BLOOM, Corey Jay ; SMITHEY, Dan ; DUBOSE, Devon Brevard</creator><creatorcontrib>FRY, David Shank ; CRAIG, Christopher Donovan ; GAUTSCHI, Jeff ; PREIGH, Michael ; LINDEMANN, Christopher M ; BLOOM, Corey Jay ; SMITHEY, Dan ; DUBOSE, Devon Brevard</creatorcontrib><description>A solid dispersion of N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and processes for preparing the solid dispersion are provided herein. Also, a pharmaceutical composition comprising a solid dispersion of N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and uses thereof are provided herein.</description><language>eng</language><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20210526&amp;DB=EPODOC&amp;CC=ZA&amp;NR=201606123B$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20210526&amp;DB=EPODOC&amp;CC=ZA&amp;NR=201606123B$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>FRY, David Shank</creatorcontrib><creatorcontrib>CRAIG, Christopher Donovan</creatorcontrib><creatorcontrib>GAUTSCHI, Jeff</creatorcontrib><creatorcontrib>PREIGH, Michael</creatorcontrib><creatorcontrib>LINDEMANN, Christopher M</creatorcontrib><creatorcontrib>BLOOM, Corey Jay</creatorcontrib><creatorcontrib>SMITHEY, Dan</creatorcontrib><creatorcontrib>DUBOSE, Devon Brevard</creatorcontrib><title>PHARMACEUTICAL COMPOSITIONS OF A ERB2 (HER2) INHIBITOR</title><description>A solid dispersion of N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and processes for preparing the solid dispersion are provided herein. Also, a pharmaceutical composition comprising a solid dispersion of N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and uses thereof are provided herein.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDAL8HAM8nV0dg0N8XR29FFw9vcN8A_2DPH09wtW8HdTcFRwDXIyUtDwcA0y0lTw9PPwdPIM8Q_iYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxUY5GBoZmBmaGRsZOxsSoAQDoSidy</recordid><startdate>20210526</startdate><enddate>20210526</enddate><creator>FRY, David Shank</creator><creator>CRAIG, Christopher Donovan</creator><creator>GAUTSCHI, Jeff</creator><creator>PREIGH, Michael</creator><creator>LINDEMANN, Christopher M</creator><creator>BLOOM, Corey Jay</creator><creator>SMITHEY, Dan</creator><creator>DUBOSE, Devon Brevard</creator><scope>EVB</scope></search><sort><creationdate>20210526</creationdate><title>PHARMACEUTICAL COMPOSITIONS OF A ERB2 (HER2) INHIBITOR</title><author>FRY, David Shank ; CRAIG, Christopher Donovan ; GAUTSCHI, Jeff ; PREIGH, Michael ; LINDEMANN, Christopher M ; BLOOM, Corey Jay ; SMITHEY, Dan ; DUBOSE, Devon Brevard</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ZA201606123B3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2021</creationdate><toplevel>online_resources</toplevel><creatorcontrib>FRY, David Shank</creatorcontrib><creatorcontrib>CRAIG, Christopher Donovan</creatorcontrib><creatorcontrib>GAUTSCHI, Jeff</creatorcontrib><creatorcontrib>PREIGH, Michael</creatorcontrib><creatorcontrib>LINDEMANN, Christopher M</creatorcontrib><creatorcontrib>BLOOM, Corey Jay</creatorcontrib><creatorcontrib>SMITHEY, Dan</creatorcontrib><creatorcontrib>DUBOSE, Devon Brevard</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>FRY, David Shank</au><au>CRAIG, Christopher Donovan</au><au>GAUTSCHI, Jeff</au><au>PREIGH, Michael</au><au>LINDEMANN, Christopher M</au><au>BLOOM, Corey Jay</au><au>SMITHEY, Dan</au><au>DUBOSE, Devon Brevard</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PHARMACEUTICAL COMPOSITIONS OF A ERB2 (HER2) INHIBITOR</title><date>2021-05-26</date><risdate>2021</risdate><abstract>A solid dispersion of N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and processes for preparing the solid dispersion are provided herein. Also, a pharmaceutical composition comprising a solid dispersion of N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and uses thereof are provided herein.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_ZA201606123B
source esp@cenet
title PHARMACEUTICAL COMPOSITIONS OF A ERB2 (HER2) INHIBITOR
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T16%3A31%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=FRY,%20David%20Shank&rft.date=2021-05-26&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EZA201606123B%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true